Human apolipoprotein E isoprotein subclasses are genetically determined.
暂无分享,去创建一个
[1] D. B. Zilversmit. Atherogenesis: a postprandial phenomenon. , 1979, Circulation.
[2] L. Dory,et al. Secretion of cholesterol-rich lipoproteins by perfused livers of hypercholesterolemic rats. , 1979, The Journal of clinical investigation.
[3] G. Utermann,et al. Different mobility in SDS—polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes Apo E‐N and Apo E‐D , 1979, FEBS letters.
[4] B. Suarez,et al. Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. , 1979, The Journal of laboratory and clinical medicine.
[5] J. Medalie,et al. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. , 1979, American journal of epidemiology.
[6] B. Bulkley,et al. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. , 1979, American journal of epidemiology.
[7] R. Mahley,et al. Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. , 1978, The Journal of biological chemistry.
[8] W. Hazzard,et al. High-density lipoproteins in myocardial infarction survivors. , 1978, Metabolism: clinical and experimental.
[9] W. Hazzard,et al. Catabolism of very low density lipoproteins in the rabbit. Effect of changing composition and pool size. , 1978, Biochimica et biophysica acta.
[10] P. Wahl,et al. Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay. , 1977, Annals of internal medicine.
[11] G. Utermann,et al. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man , 1977, Nature.
[12] W. Kannel,et al. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. , 1977, Annals of internal medicine.
[13] R. Havel,et al. Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. , 1977, Journal of lipid research.
[14] M C Hjortland,et al. Predicting coronary heart disease in middle-aged and older persons. The Framington study. , 1977, JAMA.
[15] S B Hulley,et al. HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.
[16] R. Mahley,et al. Alterations of the plasma lipoproteins and apoproteins following cholesterol feeding in the rat. , 1977, Journal of lipid research.
[17] J. Breslow,et al. Lipoprotein regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in rat liver cell cultures. , 1977, The Journal of biological chemistry.
[18] P. Alaupovic,et al. Determination of human apolipoprotein E by electroimmunoassay. , 1976, Biochimica et biophysica acta.
[19] R. Mahley,et al. Atherogenic hyperlipoproteinemia induced by cholesterol feeding the Patas monkey. , 1976, Biochemistry.
[20] T. Koschinsky,et al. A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESS , 1976, The Lancet.
[21] R. Mahley,et al. Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. , 1975, Biochemistry.
[22] P. O’Farrell. High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.
[23] R. Levy,et al. Type III hyperlipoproteinemia: an analysis of two contemporary definitions. , 1975, Annals of internal medicine.
[24] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.
[25] S. Quarfordt,et al. A new apoprotein of human plasma very low density lipoproteins. , 1974, The Journal of biological chemistry.
[26] F. Studier,et al. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. , 1973, Journal of molecular biology.
[27] R. Havel,et al. Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[28] V. Shore,et al. Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. , 1973, Biochemistry.
[29] D. Porte,et al. Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia). , 1972, Metabolism: clinical and experimental.
[30] S. Quarfordt,et al. The carbohydrate content of apolipoprotein E from human very low density lipoproteins. , 1979, Life sciences.
[31] C. Sirtori,et al. Very low density lipoproteins in normal and cholesterol-fed rabbits: lipid and protein composition and metabolism. Part 1. Chemical composition of very low density lipoproteins in rabbits. , 1976, Atherosclerosis.
[32] G. Utermann,et al. Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteins , 1975, FEBS letters.
[33] M. Mishkel,et al. A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemia. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[34] M. Marion. The Familial Hyperlipoproteinemias , 1975 .